Gilead Sciences said on Saturday that it entered into a partnership with Denmark’s LEO Pharma to develop programs to treat patients with inflammatory diseases.
Trending
- Series on life in East Germany wins International Emmy – DW – 11/25/2025
- Culture: The art of seduction according to French actor Lucas Bravo
- Reports of BBC coup ‘complete nonsense’, board member tells MPs | Ents & Arts News
- Red Cross has received body of Gaza hostage, Israeli army says
- Shein and Temu continue march across Europe as sales rise – DW – 11/10/2025
- Scammers hacked her phone and stole thousands of pounds
- Koud weer kan artrosepijn verergeren: dit helpt volgens orthopedisch chirurg
- Tatiana Schlossberg essay raises awareness of acute myeloid leukemia
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
By Reuters Econ
